PROGRAM

Invest Fair

Check

List
May 9 (Thu) 10:00-12:00, Rm.318
Session 3. What Role does JLABS play in Accelerating for Biotech?
What Role does JLABS play in Accelerating for Biotech?
  • Global Accelerator Vision and Mission
  • Melinda RichterGlobal Head, J&J Innovation-JLABS
  • 10 : 00 ~ 10 : 10
 
Panel Discussion
10 : 10 ~ 10 : 40
Introducing JLABS Korea's investment Hub Strategy
  • Session Chair
  • Sharon Chan VP Johnson and Johnson Innovation JLABS Asia Pacific, Johnson and Johnson Innovation
  • Ronne Yeo Head of Venture Relations, Johnson & Johnson Innovation JLABS, Johnson and Johnson
  • JeanFrancois Rivassou Partner, Kurma Partners
  • Jesse Huang Lead, Scientific Portfolio Engagement, JLABS NYC
  • Jiwoong Chun Managing Director, Woori
  • Pierre Beauparlant Executive Managing Director, Finchley HealthCare Ventures
 
Panel Discussion
10 : 40 ~ 11 : 10
Early-Stage Collaboration to Accelerate Innovation – From R&D to Commercialization
  • Session Chair
  • Ajay Gautam VP, Early Innovation Partnering, Asia Pacific, Early Innovation Partnering, Johnson and Johnson
  • Seung Ah LEE Deputy CEO, HUINNO
  • Jesse Huang Lead, Scientific Portfolio Engagement, JLABS NYC
  • SE-WOONG OH EVP, Yuhan R&D Institute, YUHAN CORPORATION
  • Stefan Hart Snr Director, External Innovation, Johnson and Johnson Innovation
 
Panel Discussion
11 : 10 ~ 12 : 00
Global financing environment and philosophies in Biotech
  • Session Chair
  • Daniel Parera Partner, Kurma Partners
  • Jahoon Kang Managing Director, SAMSUNG BIOLOGICS
 

BIO KOREA 2024 PARTNERS

BIO KOREA 2024 SPONSORS

  • BIO KOREA Organizing Committee
  • COMPANY NAME : BIO KOREA / REPRESENTATIVE : KIM Joo hoee, Lee Cheol-Haeng / BUSINESS LICENSE NUMBER :317-82-67128 (28159) 187 . OSONGSAENGMYEONG 2-RO, OSONG-EUP, HEUNGDEOK-GU, CHEONGJU-SI, CHUNGCHEONGBUK-DO,KOREA
    +82-1661-0810 (Oh!BIO)    biokorea@biokorea.org    www.biokorea.org
    Copyright(c) BIO KOREA. All rights reserved